awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q31157714-058415CA-EAE0-4054-BC6A-241EFA9B3AD7
Q31157714-058415CA-EAE0-4054-BC6A-241EFA9B3AD7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31157714-058415CA-EAE0-4054-BC6A-241EFA9B3AD7
Clinical results of randomized trials and 'real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research.
P2860
Q31157714-058415CA-EAE0-4054-BC6A-241EFA9B3AD7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q31157714-058415CA-EAE0-4054-BC6A-241EFA9B3AD7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
177fa6f1f213bb9f13dd5be17164dbcf24f2a964
P2860
Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATA